Affiliation:
1. Department of Veterinary Physiology and Biochemistry, Faculty of Veterinary Medicine , University of Ibadan , Ibadan , Nigeria
Abstract
Abstract
Objectives
This study examined the possible protective roles of exogenous glycine (Gly) and L-Arginine (l-Arg) against Diclofenac (DIC)-induced gastro-duodenal damage in rats.
Methods
Rats were divided into Group A (control), Group B (DIC group) and Groups C–F which were pre-treated for five days with Gly1 (250 mg/kg), Gly2 (500 mg/kg), l-Arg1 (200 mg/kg) and l-Arg2 (400 mg/kg), respectively, before co-treatment with DIC for another three days. Hematological, biochemical and histopathological analyses were then carried out.
Results
DIC produced significant (p<0.05) reduction in PCV (13.82%), Hb (46.58%), RBC (30.53%), serum total protein (32.72%), albumin (28.44%) and globulin (38.01%) along with significant (p<0.05) elevation of serum MPO activity (83.30%), when compared with control. In addition, DIC increased gastric H2O2 and MDA levels by 33.93 and 48.59%, respectively, while the duodenal levels of the same parameters increased by 19.43 and 85.56%, respectively. Moreover, SOD, GPx and GST activities in the DIC group were significantly (p<0.05) reduced in the stomach (21.12, 24.35 and 51.28%, respectively) and duodenum (30.59, 16.35 and 37.90%, respectively), compared to control. Treatment with Gly and l-Arg resulted in significant amelioration of the DIC-induced alterations although l-Arg produced better amelioration of RBC (29.78%), total protein (10.12%), albumin (9.93%) and MPO (65.01%), compared to the DIC group. The protective effects of both amino acids against oxidative stress parameters and histological lesions were largely similar.
Conclusions
The data from this study suggest that Gly or l-Arg prevented DIC-induced gastro-duodenal toxicity and might, therefore be useful in improving the therapeutic index of DIC.
Subject
Drug Discovery,Pharmacology,General Medicine,Physiology
Reference52 articles.
1. Syed, M, Skonberg, C, Hansen, SH. Mitochondrial toxicity of Diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: possible role in drug-induced liver injury (DILI). Toxicol In Vitro 2016;31:93–102. https://doi.org/10.1016/j.tiv.2015.11.020.
2. Zerbini, LF, Tamura, RE, Correa, RG, Czibere, A, Cordeiro, J, Bhasin, M, et al.. Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-Κb inhibitors in ovarian cancer therapy. PloS One 2011;6:24285. https://doi.org/10.1371/journal.pone.0024285.
3. Aydin, GI, Alparshan, G, Umen, K, Meral, NC, Ekr, UE, Nermin, K, et al.. Histopathologic changes in liver and renal tissues induced by different doses of Diclofenac sodium in rats. Turk J Vet Anim Sci 2003;27:1131–40.
4. Gomez-Lechon, MJ, Ponsoda, X, O’Connor, E, Donato, T, Castell, JV, Jover, R. Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS. Biochem Pharmacol 2003;66:2155–67. https://doi.org/10.1016/j.bcp.2003.08.003.
5. Dorado, P, Berecz, R, Caceres, MC, LLerena, A. Analysis of diclofenac and its metabolites by high-performance liquid chromatography: relevance of CYP2C9 genotype in diclofenac urinary metabolic ratios. J Chromatogr B 2003;789:437–42.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献